Cargando…
Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
Patients with castration-resistant prostate cancer (CRPC), who progress after docetaxel therapy, had until very recently, only a few therapeutic options. Recent advances in this field brought about new perspectives in the treatment of this disease. Molecular, basic, and translational research has gi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316959/ https://www.ncbi.nlm.nih.gov/pubmed/22530130 http://dx.doi.org/10.1155/2012/327253 |